Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20248-86-6

Post Buying Request

20248-86-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20248-86-6 Usage

Chemical Properties

Off-white powder

Uses

4,4''-Bis(bromomethyl)-1,1''-biphenyl is a genotoxic impurity from valsartan antihypertensive drug.

Check Digit Verification of cas no

The CAS Registry Mumber 20248-86-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,2,4 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 20248-86:
(7*2)+(6*0)+(5*2)+(4*4)+(3*8)+(2*8)+(1*6)=86
86 % 10 = 6
So 20248-86-6 is a valid CAS Registry Number.
InChI:InChI=1/C14H12Br2/c15-9-11-1-5-13(6-2-11)14-7-3-12(10-16)4-8-14/h1-8H,9-10H2

20248-86-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (725919)  4,4′-Bis(bromomethyl)biphenyl  ≥97.0% (HPLC)

  • 20248-86-6

  • 725919-1G

  • 983.97CNY

  • Detail
  • Aldrich

  • (725919)  4,4′-Bis(bromomethyl)biphenyl  ≥97.0% (HPLC)

  • 20248-86-6

  • 725919-5G

  • 2,788.11CNY

  • Detail

20248-86-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(bromomethyl)-4-[4-(bromomethyl)phenyl]benzene

1.2 Other means of identification

Product number -
Other names 1,1'-bis(bromomethyl)-4,4'-biphenyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20248-86-6 SDS

20248-86-6Relevant articles and documents

Synthesis of Polycyclic Hexapeptides Containing Multiple Intramolecular Cross-Links

Bailey, Patrick D.,Carter, Steven R.,Clarke, David G. W.,Crofts, Gavin A.,Smith, Paul W.,Ward, Peter

, p. 3215 - 3218 (1992)

Two polycyclic peptides have been prepared in which all four of the ε-nitrogens of cyclo-(Lys-Lys-Gly)2 are interconnected by intra-molecular cross-links.One of these compounds possessed (CH2)6 units between the adjacent lysyl residues and 4,4'-dimethylenebiphenyl units between the skipped lysyl residues, whilst the other contained p-xylyl units between all four of the lysyl residues.

Synthesis and characterization of Manganese(II), Cobalt(II) and Copper(II) coordination polymers with a flexible zwitterionic based ligand

?ift?i, Esengül,Ar?c?, Mürsel,Wriedt, Mario,Ye?ilel, Okan Zafer

, (2021)

Four new coordination polymers, formulated as {[MnCl(μ-bipna)](NO3)?2H2O}n (1), {[CoCl2(μ-bipna)]?2H2O}n (2), {[CuCl(μ4-bipna)]BF4?2H2O}n (3) and {[CuCl(μ4-bipna)]ClO4?2H2O}n (4) where H2bipnaBr2 = 1,1′-(1,1′-biphenyl-4,4′-diylbis(methylene))bis(3-carboxypyridin-1-ium) bromide, were synthesized under solvothermal conditions. Their structures have been characterized by single crystal and powder X-ray diffraction analyses, infrared spectra (IR) and elemental analyses. Complexes 1, 3 and 4 are isostructural and display 3-fold interpenetrated 2D → 2D structures with sql topology and the point symbol 44.62. Complex 2 exhibits a 1D coordination polymer structure, which becomes a stacked 3D supramolecular structure by hydrogen bonding and π???π interactions. The structural diversity of the compounds could be due to the conformation of the flexible zwitterionic ligands. In 2, the bipna ligand displays a cis-conformation, while in the other compounds the ligand shows a trans-conformation. The thermal and optical properties of the compounds were investigated.

Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands

Sakyiamah, Maxwell M.,Kobayakawa, Takuya,Fujino, Masayuki,Konno, Makoto,Narumi, Tetsuo,Tanaka, Tomohiro,Nomura, Wataru,Yamamoto, Naoki,Murakami, Tsutomu,Tamamura, Hirokazu

supporting information, p. 1130 - 1138 (2019/02/16)

The chemokine receptor CXCR4/stromal cell-derived factor-1 (SDF-1: CXCL12) signaling axis represents a crucial drug target due to its relevance to several diseases such as HIV-1 infection, cancer, leukemia, and rheumatoid arthritis. With the aim of enhancing the binding affinity and anti-HIV activity of a potent CXCR4 ligand as a lead, 23 low molecular weight compounds containing dipicolylamine (Dpa) and cyclam cationic moieties with varying spacers and spatial positioning were designed, synthesized and biologically evaluated. All of the synthesized compounds screened at 1.0 μM in the NanoBRET assay system exhibited >70% inhibition of the binding of a competitive probe TAMRA-Ac-TZ14011 (10 nM) to CXCR4 in the presence of zinc (II) ion. Furthermore, selected compounds 3, 8, 9, 19 and 21 with spatial distances between the next carbon to Dpa and the next carbon to cyclam within the range of 6.5–7.5 ? showed potent binding affinity selective for CXCR4 with IC50 values of 1.6, 7.9, 5.7, 3.5 and 4.5 nM, respectively, with corresponding high anti-HIV activity with EC50s of 28, 13, 21, 28 and 61 nM, respectively, in the presence of zinc (II) ion. Some compounds with remarkably more potent CXCR4-binding affinity than that of an initial lead were obtained. These compounds interact with different but overlapping amino acid residues of CXCR4. The present studies have developed new low molecular weight CXCR4 ligands with high CXCR4-binding and anti-HIV activities, which open avenue into the development of more potent CXCR4 ligands.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20248-86-6